Search research articles
Contact Us
Filters
Showing results (251-260 of 267) with videos related to
Page
of 27
Sort By:
Hepatology International
|
August 12, 2009
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)
Gamal Shiha, Shiv Kumar Sarin, Alaa Eldin Ibrahim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 18, 2022
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Maud Lemoine, Lambert Assoumou, Pierre-Marie Girard, et al.
Scientific Reports
|
November 3, 2024
Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective study
Maëna Le Corvec, Marwin A Farrugia, Eric Nguyen-Khac, et al.
Science Translational Medicine
|
December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
Olivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Hepatology International
|
October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
Gamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Journal of Hepatology
|
April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>
Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Hepatology Communications
|
July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
Rebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
The New England Journal of Medicine
|
February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated Steatohepatitis
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 267) with videos related to
Sort By:
Page
of 27
Hepatology International
|
August 12, 2009
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)
Gamal Shiha, Shiv Kumar Sarin, Alaa Eldin Ibrahim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 18, 2022
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Maud Lemoine, Lambert Assoumou, Pierre-Marie Girard, et al.
Scientific Reports
|
November 3, 2024
Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective study
Maëna Le Corvec, Marwin A Farrugia, Eric Nguyen-Khac, et al.
Science Translational Medicine
|
December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
Olivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Hepatology International
|
October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
Gamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Journal of Hepatology
|
April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>
Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Hepatology Communications
|
July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
Rebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
The New England Journal of Medicine
|
February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated Steatohepatitis
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 27